Bioprocessing has always been a bit late in adopting the latest engineering techniques, e.g., computational fluid dynamics to bioreactor design.

Crown BioScience experts explore organoid models and high-content imaging to evaluate T-cell-targeted therapies and ...

Citation: Successful CAR-T cell therapy for end-stage multiple myeloma using advanced cellular product performed in Hong Kong (2025, March 27) retrieved 24 April 2025 from https://medicalxpress ...

DELRAY BEACH, Fla., April 21, 2025 /PRNewswire/ -- The global Cell Based Assays Market, valued at US$17.29 billion in 2024, is forecasted to grow at a robust CAGR of 9.1%, reaching US$17.84 ...

The initiative aims to improve infectious disease management. T Cell Diagnostics Pte. Ltd. (TCD) has licensed an intellectual ...

PC-CD is characterized by interfollicular sheets of plasma cells ... Indolent T/B-lymphoblastic proliferation: Seen in CD with clusters of immature lymphoblasts that lack atypia and clonality ...

Reproducibility of cell-based assays is one of the key points when it comes to reliability of experimental data. Despite of choosing the appropriate assay type, there are many more factors to be ...

NICE has approved Novartis’ CAR-T therapy Kymriah (tisagenlecleucel) for diffuse large B-cell lymphoma (DLBCL) in adults who did not respond to two or more previous treatments. The drug will be ...

Gilead Sciences’ Kite Pharma unit is closing on approval of its second European approval for a CAR-T for cancer, after the CHMP backed its KTE-X19 therapy for mantle cell lymphoma. The EMA’s ...

In that sense, T-Mobile's Essentials Choice 55 plan is the best cell phone plan for seniors overall due to the relative value of its discounted pricing and the carrier's widespread brick-and ...